ResMed's first-quarter result broadly met market expectations, though rising margins and potential for further capital ...

Tariffs on medical devices would push up prices and disrupt research and development efforts at the expense of US patients, ...

Earlier this year, Resmed unveiled a new comprehensive brand evolution in an effort to streamline its various services.

Let's see which shares analysts are tipping as buys this month. The post Where to invest $10,000 in ASX shares in November ...

Resmed is making another strategic investment in U.S.-based manufacturing and distribution, this time in Indianapolis. The move aims to position the company’s inventory of CPAP devices ...

Key opportunities in the UK sleep apnea devices market include leveraging rising demand for efficient healthcare, expanding AI and ML integration for personalized care, and catering to an aging, ...

Pacific Sleep Apnea Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

Respondents saw improved sleep patient volume growth in the last 12 months, but they expect slower growth in the next 12 months, according to the 3Q25 HME Sleep and Oxygen Survey from ...

CEOs Karen Borg and Amrita Blickstead took the reins of the dental sleep appliance maker in February last year, they had some ...

"And so it's a really exciting time in sleep apnea research, in that there's a bunch of different options being looked at." ...

ResMed Inc. closed 16.14% below its 52-week high of $293.81, which the company reached on August 22nd.

Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to ...